...
机译:肾功能的顺序变化与心房颤动患者中风和死亡风险
University of Birmingham Centre for Cardiovascular Sciences City Hospital Birmingham United;
Department of Geriatric Cardiology Chinese PLA General Hospital Beijing China;
Department of Geriatric Cardiology Chinese PLA General Hospital Beijing China;
Department of Geriatric Cardiology Chinese PLA General Hospital Beijing China;
Department of Geriatric Cardiology Chinese PLA General Hospital Beijing China;
Department of Geriatric Cardiology Chinese PLA General Hospital Beijing China;
Department of Geriatric Cardiology Chinese PLA General Hospital Beijing China;
University of Birmingham Centre for Cardiovascular Sciences City Hospital Birmingham United;
Atrial fibrillation; Bleeding; Death; Renal function; Stroke;
机译:房颤患者肾脏功能的顺序变化以及中风和死亡的风险
机译:肾功能的顺序变化与心房颤动患者中风和死亡风险
机译:对有关“非瓣膜性房颤患者中风和全身性栓塞的预测指标:肾功能不全:ROCKET AF(Rivaroxaban每日一次,口服,直接因素)中的R(2)CHADS(2)指数的验证的答复Xa抑制与维生素K拮抗剂在房颤预防卒中和栓塞试验中的比较以及ATRIA(房颤的抗凝和危险因素)研究队列”
机译:永久性心房纤颤患者心率变异性的多尺度熵特征分析以预测缺血性中风风险
机译:高敏C反应蛋白和房颤的卒中风险:卒中地理和种族差异的原因(REGARDS)研究
机译:与性别相关的危险因素差异所接受的治疗方式心房颤动和急性中风患者的治疗和预后:RAF研究(急性患者的早期复发和脑出血)缺血性中风和心房颤动)
机译:回应关于物品的信,“肾功能障碍是非衰弱性心房颤动患者中风和全身栓塞的预测因子:验证R 2 Chads 2指数在火箭AF中(rivaroxaban曾经每日,口服,直接因子XA抑制相比维生素K对患者预防心房颤动的卒中和栓塞试验的拮抗剂)和Atria(心房颤动的抗凝和危险因素)研究队列“